ABSTRACT
Mex+ human lymphoma cell lines contain 06-methylguanine-DNA methyltransferase, a DNA repair enzyme that undergoes suicide inactivation on interaction with its substrate. The cells are therefore competent to remove the alkylation lesion 06-methylguanine from their DNA. However, several repair-deficient lymphoma cell lines (Mex-) are also known. It is shown here that Mex+ cells can be converted temporarily to a Mex-phenotype by growth in nontoxic concentrations of free 06-methylguanine. The depletion of methyltransferase activity is not a result of O'-methylguanine incorporation into DNA and subsequent demethylation by the enzyme. It is proposed that 06-methylguanine is mistakenly incorporated into tRNA molecules by means ofa post-transcriptional ribosyl transfer reaction. The demethylation of such bases in tRNA has been demonstrated by using bacterial and human DNA repair enzymes. The existence ofsuch a subversive repair of a methylated base in tRNA raises the possibility of competition between DNA and RNA for cellular DNA repair enzymes. Furthermore, it is proposed that the known aberrant methylation of tRNA in certain transformed cells, together with subversive tRNA repair, could account for the Mex-phenotype.
To counter the effects of cytotoxic and mutagenic methylating agents, cellular repair mechanisms recognize and remove most types of methylated bases from DNA. This removal is commonly initiated by DNA glycosylases that excise the methylated residue as a free purine or pyrimidine base (1, 2) . In contrast, DNA is freed of the important lesion o6-methylguanine (O6MeGua) by O6MeGua-DNA methyltransferase (O6MeGua MeTase), which abstracts the methyl group from the 06 position of guanine and transfers it to one of its own cysteine residues (3). The reaction mechanism is similar in bacteria and mammalian cells (4, 5) and is unusual in being stoichiometric; each MeTase molecule can repair only a single O6MeGua residue.
Since uncorrected O6MeGua residues in DNA are mutagenic, the distribution of MeTase activity among different organs and cell types has been the focus of considerable recent attention. The O6MeGua MeTase is present in varying levels in different cells, and there is a reasonable inverse correlation in rat tissues between MeTase activity and the site of tumor induction by methylating carcinogens (6) . Moreover, although all untransformed human cells so far examined contain active MeTase, malignant transformation may result in cell lines that lack measurable activity (7, 8) . Such cell lines, designated Mex-(or Mer), are defective in the removal of O6MeGua from DNA in vivo (8, 9) . Cells of the Mex-phenotype exhibit an increased sensitivity to killing by methylating agents (10) .
It has been suggested that an important feature of damage reversal by methyl group transfer is that it avoids the generation of free O6MeGua (11) . Pathways exist to scavenge purines for reincorporation into DNA and RNA. Since DNA polymerases will accept 06Me-dGTP and incorporate the methylated nucleotide in place of dAMP into DNA in vitro (12) , the potential exists in vivo for the incorporation of free 06MeGua into DNA, where its ability to code ambiguously may represent a mutagenic threat to the cell.
This study was undertaken to investigate whether free O6MeGua could be incorporated into DNA and interfere with the cellular capacity to repair alkylation damage. It was found that incorporation into DNA does not occur to any appreciable extent and that the incorporation of the base into tRNA may be a critical event.
MATERIALS AND METHODS
Cell Culture. Raji TK+ and Raji TK-cell lines were obtained from G. Klein, Stockholm. Cells were maintained in RPMI 1640 medium (GIBCO) supplemented with 10% fetal calf serum. Routine checks confirmed that cultures were free of mycoplasma contamination. Cells exhibiting spontaneous resistance to 6-thioguanine were selected by the method of Penman et al. (13 
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Analysis and Purification of O6MeGua and O6MeGuo. The methylated base and nucleoside were further purified by preparative HPLC before use. Unlabeled O6MeGua and 06[3H]MeGua were purified by chromatography on a Varian micropak MCH-10 reverse-phase column with a Varian 5000 liquid chromatograph. Samples were eluted isocratically with 25% aqueous methanol at a flow rate of 1 ml/min. Both the UV absorbance (A254) and the fluorescence of the column eluate were monitored. Fluorescence was measured by passage through the flow cell of a Perkin-Elmer LS-3 fluorescence spectrometer. An excitation wavelength of 295 nm was used and emission was monitored at 395 nm. This has the advantage of substantially reducing the fluorescence of adenine and its derivatives while affecting O6MeGua and its derivatives only slightly. Fractions containing the fluorescent O6MeGua were pooled and lyophilized.
The purity of O6MeGua was checked by ion-exchange chromatography on a Whatman Partisil 10/25 SCX column, developed with a gradient of ammonium formate in 6% aqueous methanol. It contained a single UV-absorbing peak that coincided with the fluorescent material at the previously determined position of elution of O6MeGua (14) and contained <1% contamination with guanine or 6-chloroguanine.
O6MeGuo was also purified by reverse-phase chromatography on MCH-10. The eluted O6MeGuo exhibited a single fluorescent and UV-absorbant peak following lyophilization and rechromatography under the same conditions. The coincident peaks of absorbance and fluorescence were completely abolished by prior incubation with adenosine deaminase, which is known to demethylate O6MeGuo (15) .
Analysis of nucleoside digests of tRNA was performed by reverse-phase chromatography on MCH-10 developed isocratically with 20% aqueous methanol. The elution times of relevant reference compounds are guanine, 6 min; O6MeGuo, 16 min; O6MeGua, 30 min.
Enzyme Assays. Preparation of lymphoma cell extracts for assay of O6MeGua MeTase was carried out as follows. Generally, 1-3 x 107 cells in exponential growth were harvested from 40 ml of medium by low-speed centrifugation, washed twice by resuspension in phosphate-buffered saline, and suspended in 150-400 ,.l of extraction buffer (50 mM Tris-HCl, pH 7.8/10 mM EDTA/10 mM dithiothreitol/0.3 M KCl). Cell suspensions were disrupted by sonication at 0°C. Crude extract were clarified by centrifugation at 4°C and used to assay 06MeGua MeTase as described by Harris et al. (16) .
Homogeneous Escherichia coli MeTase, fraction VI (ref. 14), was assayed as described (14) except that a final volume of 500 ,ul was employed. MeTase activity on MNU-treated tRNA was determined in an analogous fashion. The assay volumes and buffers were the same except 5 mM MgCl2 replaced 1 mM EDTA in the reaction mixture. Each assay contained 4-8 ,ug of methylated tRNA (1-2 x 104 cpm) and following incubation, usually for 10 min at 37°C, RNA was digested to ethanol-soluble oligonucleotides by pancreatic RNase. Protein was removed by precipitation with ethanol and the supernatants containing the oligonucleotides were evaporated to dryness, dissolved in 50 mM Tris HCl, pH 8.0/10 mM MgCl2, and further digested to nucleosides by the successive addition of pancreatic RNase, phophodiesterase, and bacterial alkaline phosphatase (heated for 5 min at 95°C to destroy contaminating adenosine deaminase activity). The digests were analyzed by reverse-phase HPLC as described above. The precipitated protein was redissolved and successively digested with proteinase K followed by aminopeptidase M. The protein hydrolysate was supplemented with authentic S-methylcysteine and analyzed by descending chromatography on Whatman 3MM paper as described (3). (Fig. 1 ).
Since the Raji TK' and Raji TK-lines share a common origin, they were used to investigate the effects of free 06MeGua on Mex+ and Mex-cells.
Effect of Free 06MeGua on Cellular 06MeGuw MeTase Levels. Continuous growth in the presence of 06MeGua at concentrations of <0.3 mM was nontoxic to both Raji TK+ and TK-cells. However, exposure to such nontoxic concentrations of 06MeGua reduced the level of 06MeGua MeTase activity in Raji TK+ cells. Fig. 2 shows that cells grown for 16 hr in medium containing up to 0.1 mM O6MeGua were depleted of the MeTase in a concentration-dependent manner, whereas extracts of cells grown in the presence of equivalent concentrations of guanine or adenine contained normal levels of enzyme activity. Extracts of Raji TK' cells grown with >0.1 mM 06MeGua contained no detectable o6_ MeGua MeTase activity. This reduction in activity was not due to enzyme inhibition by residual free 06MeGua present in the cell extracts, as separate experiments confirmed that (Fig. 2 ). Since these 6-thioguanine-resistant sublines lack one salvage pathway for purines and O6MeGua is not a substrate for adenine phosphoribosyltransferase (see Materials Since free O6MeGua, its ribo-or deoxyribonucleoside (19) , or O6MeGua residues in DNA did not seem to account for the enzyme inactivation, the possibility that O6MeGua might be incorporated into RNA to provide a substrate for the MeTase was considered. Incorporation of the nucleotide during transcription seemed unlikely because this route should be dependent on functional pathways of purine salvage. Transfer RNA, however, undergoes numerous post-transcriptional modifications, of which two known examples utilize a free purine base as substrate.
The possibility that tRNA containing O6MeGua would be a substrate for O6MeGua MeTase was tested by using the homogeneous E. coli enzyme of Demple et al. (14) (Fig. 3 Lower). It is concluded that tRNA containing O6MeGua residues is a substrate for the O6MeGua MeTase.
The corresponding human O6MeGua MeTase is not available in highly purified form. Nevertheless, crude extracts of Raji TK+ cells were able to catalyze the disappearance of 06[3H]MeGuo from [3H]MNU-treated tRNA (Fig. 4) . The likelihood that this removal was effected by the O6MeGua
MeTase was supported by the observation that extracts of Raji TK-cells, which contained normal amounts of another DNA repair enzyme, 3-methyladenine-DNA glycosylase, were unable to carry out the reaction (Fig. 5 ).
DISCUSSION
The finding that the O6MeGua in tRNA can be recognized and demethylated by the homogeneous O6MeGua MeTase of E. coli or the analogous enzyme in extracts of human cells together with the observation that depletion of MeTase is not due to O6MeGua incorporation into cellular DNA (see also ref. 20) suggest that tRNA metabolism could be involved in the reversible conversion to the Mex-phenotype demonstrated here. The first position of the anticodon of several tRNA species from many organisms may contain a modified nucleoside (21) . For example, queuine or hypoxanthine can be inserted into specific sites of certain tRNA species in ribosyl transfer reactions that displace free guanine from the precursor tRNA (22, 23 (25, 26) . Inactivation of particular tRNA species is unlikely, on the grounds of target size, to be a major factor in the biological effects of methylating agents. However, the tRNA population as a whole comprises a target of similar size to genomic DNA and the partial inactivation or subversion of the DNA repair capacity by methylated tRNA molecules must now be considered as a possible contributory factor to cell killing or mutagenesis by such agents.
The ability of methylated tRNA to serve as a substrate for a DNA repair enzyme may underlie the Mex-phenotype. tRNA contains a wide variety of methylated bases (21) and all mammalian cells contain a number of specific tRNA MeTases (27) . Alteration oftRNA MeTase levels is a consistent feature of the malignant state (28) . This may result in the production of novel methylated bases in some tumor tRNA species (29, 30) . Transformation by simian virus 40, an event that in many cases results in the transition from a Mex+ to Mex-phenotype, is also associated with altered tRNA MeTase activity (31) . It is proposed that in certain transformed cells, aberrant methylation results in 06MeGuo (or possibly 04-ribothymidine) in tRNA molecules. These methylated nucleosides are recognized and repaired by the suicidal 06MeGua MeTase. Consequently, no active 06MeGua MeTase molecules remain available to correct 06MeGua in DNA-i.e., the cells are Mex-. In this model, the lack of 06MeGua MeTase in Mex-cells is an epigenetic event; expression of the 06MeGua MeTase gene(s) is normal and the levels of active enzyme are determined by the rate of aberrant tRNA methylation.
Two lines of evidence support such a model. First, the intracellular distributions of tRNA MeTase and the repair enzymes are similar-the major fraction of both enzymes is found in the cytoplasm, although both are present in the nucleus (19, 32) . Second, Ayres et al. (33) found no evidence for a diffusible regulator able to activate or repress the MeTase gene in hybrids between Mex+ and Mex-cells. This is compatible with the full expression of both sets of 06MeGua MeTase genes and the subsequent inactivation of a fraction of the enzyme molecules.
Treatment of Mex+ cells with low concentrations of MNNG also depletes them of 06MeGua MeTase (34) . Such treatment sensitizes the cells to the toxic effects of a subsequent exposure to a variety of related alkylating agents (35) . Because of the highly reactive nature of MNNG, this sensitization could be mediated by several means, including 5288 Biochemistry: Karran 
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interference with intracellular thiol levels or direct reaction with DNA repair enzymes. An advantage of depletion of O6MeGua MeTase by growth in free 06MeGua is that the effect should be more specific. By using this approach, it has been shown that MeTase depletion results in sensitization to the mutagenic but not the cytotoxic effects of methylating agents (36 
